CD34 and myeloproliferative neoplasm: It is difficult to find an appropriate cellular model reflecting the genetic basis and molecular profiling of MPNs, so a few research groups have analyzed calreticulin’s role in these diseases using circulating CD34+ cells or cells cultured from blood or bone marrow samples of patients with MPN [38,44,45,46,47].